3. Clinical features
Virus causes endothelial dysfunction with development
of leaky capillaty syndrome
All HF start with high fever and severe body pains
Often assoc with sore throat
Hypovolaemic shock ARDS can develop
Leucopenia, thrombocytopenia and protinuria common
Lassa fever - reterosternal pain, pharyngitis, protinuria,
joint and abdominal pain, encephalopathy & ARDS
In Lassa fever Ribavirin ivi is effective
6. Dengue fever
It is most common arthropod borne viral
disease
Endemic in India, Bangladesh, Myanmar,
Thailand and Sri Lanka
Sporadic and epidemics reported from
America, Africa
7. Dengue fever
Agent: flavivirus group (group B arborvirus)
Four serotypes
All cause a similar clinical syndrome
Homolytic immunity life long
Heterotypic immunity between serotypes
is for few months only
Incubation period: 5-6 days
8. Dengue fever
Vector: Aedes aegypti
Breeding in stationary water
Inhabits dwellings
Bites during day
Transmission:
More during rainy season and in tropics
Cycle is man - mosquito - man
10. Dengue fever
1. Prodrome : 02 days - malaise , headache
2. Acute onset : fever, backache, arthralgia, headache,
generalised bodyache (bone breaking fever), A, N, V,
retro-orbital pain, lacrimation, scleral congestion. May
have relative bradycardia and LNopathy
3. Fever : continous or ‘saddle back type’ usually lasts
7-8 days
4. Rash : transient maular rash on first 1-2 days, scarlet
morbilliform rash on days 3-5 on trunk spreading
centrifugally, spares palms and soles
5. Convalescence : slow
11. Dengue hemorrhagic fever
More common in south east Asia
There is fever along with presence of
Petechiae
Ecchymoses
epistaxis
GI bleed
Bleeding diathesis
12. Dengue Shock syndrome
Occur commonly in children
Occurs after three days of fever
There is fever +
Features of DHF +
Severe hypotension and circulatory failure with
features of capillary leak syndrome
Adults do not have classical DSS but have
GI hemorrhage
Haemostatic abnormalities
Increased liver enzymes
13. Pathogenesis of DHF and DSS
Exact pathogenesis is unclear
Presence of pre-existing immunity to a dengue
virus serotype, heterotypic to one causing
current infection predisposis to development of
syndrome
Presence of these heterotypic antibodies
facilitates increased viral entry and replication
in the monocytes
Triggers an immunological response
14. Pathogenesis of DHF and DSS...
Viral infection in presence of preexisting antibodies triggers
an immunopathological reaction
release of vasoactive peptides activation of compliment system
vascular damage DIC
at post cap endoth. junctions
Hemorrhage & rash bleeding diathesis
Shock
15. Diagnosis & Investigations
Clinical features in an endemic area
Positive tourniquet test (>20 petechiae per sq inch)
Thrombocytopenia <1 lac / cu mm
Leucopenia
Hemoconcentration (Hct > 20% of base line)
Serological tests : detection of IgM antibodies
Appear at end of one week of symptoms
Remain positive for 1-3 months
Rising titers are confirmatory
Detection of virus / viral antigen from blood
16. Management
Symptomatic and supportive
Antipyretics, analgesics and tepid sponging
Paracetamol preferred
Avoid aspirin
Management of shock
Volume replacement with NS / RL / DNS
Blood transfusion and FFP splly if shock and DIC present
Steroids No
Antivirals use